Cart summary

You have no items in your shopping cart.

Levobetaxolol hydrochloride

SKU: orb1300654

Description

Levobetaxolol hydrochloride

Research Area

Neuroscience, Pharmacology & Drug Discovery

Images & Validation

Key Properties

CAS Number116209-55-3
MW343.89
Purity99.69%
FormulaC18H29NO3·HCl
SMILESCl.CC(C)NC[C@H](O)COc1ccc(CCOCC2CC2)cc1
TargetAdrenergic Receptor
Solubility10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.82 mM);H2O:63 mg/mL (183.2 mM);Ethanol:64 mg/mL (186.11 mM);DMSO:50 mg/mL (145.4 mM)

Bioactivity

Target IC50
β2-adrenoceptor:32.6 nM(Ki)|β1-adrenoceptor:0.76 nM(Ki)
In Vivo
Levobetaxolol (150 mg/eye) is more potent than dextrobetaxolol, reducing intraocular pressure by 25.9% in conscious ocular hypertensive cynomolgus monkeys. Levobetaxolol (20 mg/kg) significant protects retinal function and results in significantly thicke the RPE and outer nuclear layer in a photic-induced retinopathy rat model. Levobetaxolol (20 mg/kg) results in a 10-fold up-regulation of bFGF and a two-fold up-regulation of CNTF mRNA levels, trophic factors that have been shown to inhibit retinal degeneration in a number of species.
In Vitro
Levobetaxolol potently antagonizes functional activities at cloned human β1 and β2 receptors, and also at guinea pig atrial β1, tracheal β2 and rat colonic β3 receptors with IC50 of 33.2 nM, 2970 nM and 709 nM, respectively Levobetaxolol (Ki = 16.4 nM) is more potent than dextrobetaxolol (Ki = 2.97 μM) at inhibiting isoproterenol-induced cAMP production in human non-pigmented ciliary epithelial cells. Levobetaxolol (topically applied) has been shown to reac the back o the eye in sufficient quantities to protect retinal ganglion cells from various types of insults. Levobetaxolol displaces [3H]-nitrendipine for L-type voltage-dependent calcium channel receptor with IC50 of 29.5 μM in rat cortex. Levobetaxolol reduces nMDA-stimulated 45Ca2+ influx by 47.3%. Levobetaxolol (topically applied) reduce the b-wave amplitude caused by ischaemia/reperfusion.

Storage & Handling

StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
DisclaimerFor research use only

Alternative Names

β1-adrenergic receptor, β2-adrenergic receptor, Inhibitor, Levobetaxolol, Levobetaxolol HCl, Levobetaxolol hydrochloride, Levobetaxolol Hydrochloride, inhibit, Betaxolol Hydrochloride, Betaxon, (S)-Betaxolol, (S)-Betaxolol hydrochloride, Adrenergic Receptor, AdrenergicReceptor, AL-1577A, Beta Receptor

Similar Products

  • Levobetaxolol HCl [orb1222840]

    >98% (HPLC)

    116209-55-3

    343.9

    C18H29NO3·HCl

    1 g, 500 mg, 25 mg, 50 mg, 100 mg, 200 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Levobetaxolol hydrochloride (orb1300654)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

1 ml x 10 mM (in DMSO)
$ 70.00
25 mg
$ 70.00
50 mg
$ 90.00
DispatchUsually dispatched within 3-5 working days
Bulk Enquiry